Literature DB >> 17339163

Mutational analysis of PTPN11 gene in Taiwanese children with Noonan syndrome.

Chia-Sui Hung1, Ju-Li Lin, Yann-Jinn Lee, Shuan-Pei Lin, Mei-Chyn Chao, Fu-Sung Lo.   

Abstract

Noonan syndrome (NS) is an autosomal dominant disorder presenting with characteristic facies, short stature, skeletal anomalies, and congenital heart defects. Mutations in protein-tyrosine phosphatase, nonreceptor-type 11 (PTPN11), encoding SHP-2, account for 33-50% of NS. This study screened for mutations in the PTPN11 gene in 34 Taiwanese patients with NS. Mutation analysis of the 15 coding exons and exon/intron boundaries was performed by polymerase chain reaction and direct sequencing of the PTPN11 gene. We identified 10 different missense mutations in 13 (38%) patients, including a novel missense mutation (855T>G, F285L). These mutations were clustered in exon 3 (n = 6) encoding the N-SH2 domain, exon 4 (n = 2) encoding the C-SH2 domain, and in exons 8 (n = 2) and 13 (n = 3) encoding the PTP domain. In conclusion, this study provides further support that PTPN11 mutations are responsible for Noonan syndrome in Taiwanese patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339163     DOI: 10.1016/S0929-6646(09)60235-7

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  8 in total

1.  Congenital Chylothorax as the Initial Presentation of PTPN11-Associated Noonan Syndrome.

Authors:  Darius Ebrahimi-Fakhari; Eli Freiman; Monica H Wojcik; Katie Krone; Alicia Casey; Ariel S Winn; Amy E Roberts; Beth D Harper
Journal:  J Pediatr       Date:  2017-03-28       Impact factor: 4.406

2.  Noonan syndrome in diverse populations.

Authors:  Paul Kruszka; Antonio R Porras; Yonit A Addissie; Angélica Moresco; Sofia Medrano; Gary T K Mok; Gordon K C Leung; Cedrik Tekendo-Ngongang; Annette Uwineza; Meow-Keong Thong; Premala Muthukumarasamy; Engela Honey; Ekanem N Ekure; Ogochukwu J Sokunbi; Nnenna Kalu; Kelly L Jones; Julie D Kaplan; Omar A Abdul-Rahman; Lisa M Vincent; Amber Love; Khadija Belhassan; Karim Ouldim; Ihssane El Bouchikhi; Anju Shukla; Katta M Girisha; Siddaramappa J Patil; Nirmala D Sirisena; Vajira H W Dissanayake; C Sampath Paththinige; Rupesh Mishra; Eva Klein-Zighelboim; Bertha E Gallardo Jugo; Miguel Chávez Pastor; Hugo H Abarca-Barriga; Steven A Skinner; Eloise J Prijoles; Eben Badoe; Ashleigh D Gill; Vorasuk Shotelersuk; Patroula Smpokou; Monisha S Kisling; Carlos R Ferreira; Leon Mutesa; Andre Megarbane; Antonie D Kline; Amy Kimball; Emmy Okello; Peter Lwabi; Twalib Aliku; Emmanuel Tenywa; Nonglak Boonchooduang; Pranoot Tanpaiboon; Antonio Richieri-Costa; Ambroise Wonkam; Brian H Y Chung; Roger E Stevenson; Marshall Summar; Kausik Mandal; Shubha R Phadke; María G Obregon; Marius G Linguraru; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2017-07-27       Impact factor: 2.802

Review 3.  Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature.

Authors:  Fu-Sung Lo; Ju-Li Lin; Min-Tzu Kuo; Pao-Chin Chiu; San-Ging Shu; Mei-Chyn Chao; Yann-Jinn Lee; Shuan-Pei Lin
Journal:  Eur J Pediatr       Date:  2008-10-29       Impact factor: 3.183

4.  Hodgkin's lymphoma in a patient with Noonan syndrome with germ-line PTPN11 mutations.

Authors:  Fu-Sung Lo; Tseng-Tong Kuo; Chao-Jan Wang; Min-Tzu Kuo; Ming-Chung Kuo
Journal:  Int J Hematol       Date:  2008-08-30       Impact factor: 2.490

5.  Objective differential diagnosis of Noonan and Williams-Beuren syndromes in diverse populations using quantitative facial phenotyping.

Authors:  Antonio R Porras; Marshal Summar; Marius George Linguraru
Journal:  Mol Genet Genomic Med       Date:  2021-03-27       Impact factor: 2.183

6.  Noonan syndrome - a new survey.

Authors:  Alireza Tafazoli; Peyman Eshraghi; Zahra Kamel Koleti; Mohammadreza Abbaszadegan
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

7.  Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.

Authors:  Jeevana Praharsha Athota; Meenakshi Bhat; Sheela Nampoothiri; Kalpana Gowrishankar; Sanjeeva Ghanti Narayanachar; Vinuth Puttamallesh; Mohammed Oomer Farooque; Swathi Shetty
Journal:  BMC Med Genet       Date:  2020-03-12       Impact factor: 2.103

8.  A PTPN11 allele encoding a catalytically impaired SHP2 protein in a patient with a Noonan syndrome phenotype.

Authors:  Jonathan J Edwards; Simone Martinelli; Luca Pannone; Ivan Fai-Man Lo; Lisong Shi; Lisa Edelmann; Marco Tartaglia; Ho-Ming Luk; Bruce D Gelb
Journal:  Am J Med Genet A       Date:  2014-05-28       Impact factor: 2.802

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.